Voorbeelden van het gebruik van Kabi in het Engels en hun vertalingen in het Nederlands
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
What DOCETAXEL KABI is and what it is used for?
What DOCETAXEL KABI looks like and contents of the pack?
DOCETAXEL KABI contains alcohol.
See also section“DOCETAXEL KABI contains ethanol(alcohol)” below.
Tabulated list of adverse reactions in head and neck cancer for DOCETAXEL KABI 75 mg/m² in combination with cisplatin and 5-fluorouracil.
Tabulated list of adverse reactions in prostate cancer for DOCETAXEL KABI 75 mg/m² in combination with prednisone or prednisolone.
Tabulated list of adverse reactions in prostatecancer for DOCETAXEL KABI 75 mg/m² in combination with prednisone or prednisolone.
DOCETAXEL KABI 120 mg/6 ml concentrate for solution for infusion requires NO prior dilution with a solvent
DOCETAXEL KABI in combination with capecitabine is indicated for the treatment of patients with locally advanced
DOCETAXEL KABI in combination with cisplatin
DOCETAXEL KABI in combination with prednisone
DOCETAXEL KABI monotherapy is indicated for the treatment of patients with locally advanced
DOCETAXEL KABI was administered as a 1-hour infusion,
Before each treatment with DOCETAXEL KABI, you will have blood tests to check that you have enough blood cells and sufficient liver function to receive DOCETAXEL KABI.
Aseptically withdraw the required amount of DOCETAXEL KABI concentrate for solution for infusion using a calibrated syringe.
Tabulated list of adverse reactions in gastric adenocarcinoma center for DOCETAXEL KABI 75 mg/m² in combination with cisplatin and 5-fluorouracil.
It is important that you read the entire contents of this guide prior to the preparation of the DOCETAXEL KABI infusion solution.
DOCETAXEL KABI in combination with cisplatin
DOCETAXEL KABI in combination with doxorubicin is indicated for the treatment of patients with locally advanced
DOCETAXEL KABI in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours over express HER2